Søgning på udtrykket 'hepatitis b' giver 53 resultater
Dokumenter [5] Sider [2] Kalender [5] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [5]
Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Se…
Program og tilmelding
Ved Andrea Sinclair, SSI
Sider [2]
…: Anne Øvrehus (tovholder), Peer Brehm Christensen, Nina Weis, Britta Tarp, Lone Mygind National Strategi for Hepatitis C (Sundhedsstyrelsen 2023), Kronisk viral hepatitis: Nina Weis (tovholder), Peer Brehm Christensen, Alex Lund Laursen Hepatitis B (2018), Hepatitis C (2022), HIV: Antiretroviral terapi: Jan Gerstoft (tovholder), Jens Lundgren, Henrik Nielsen, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smi…
Professor Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom. Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi. Denne artikel gennemgår naturhistorien, kendte og nye biomark…
Kalender [5]
10. juni, Nielsine Nielsen Auditoriet, Panum, København
17. juni 2022, Auditorium 3+4, Hvidovre Hospital
5. juli 2014, Sigtuna, Sverige
1. maj 2014, Berlin, Tyskland
7. november 2011, Auditorium 93, Rigshospitalet
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?BMC Infectious Diseases
25.07.2024
. Abstract. . Background and aims. Numerous HBeAg-positive chronic hepatitis B (CHB) patients with persistently normal ALT have significant liver histopathology. It is imperative to identify true “immune tolerant” patients. We aimed to evaluate the liver histopathology features of HBeAg-positive CHB patients with normal ALT and the incidence of liver cirrhosis and HCC in CHB patients during follow-up. . …
Journal of Medical Virology
24.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
BMC Infectious Diseases
24.07.2024
. Abstract. . Background and aims. Numerous HBeAg-positive chronic hepatitis B (CHB) patients with persistently normal ALT have significant liver histopathology. It is imperative to identify true “immune tolerant” patients. We aimed to evaluate the liver histopathology features of HBeAg-positive CHB patients with normal ALT and the incidence of liver cirrhosis and HCC in CHB patients during follow-up. . …
Journal of Medical Virology
23.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Journal of Medical Virology
18.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Journal of Medical Virology
17.07.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Journal of Infectious Diseases
14.07.2024
Abstract . Background . Approximately 296 million people suffer from chronic hepatitis B (CHB) caused by hepatitis B virus (HBV). Current standard treatment, nucleos(t)ide analogs, are not efficient enough to eradicate HBV from the hepatocytes. Thus, developing new drugs for CHB is desired to achieve complete cure.Methods . Here we established a novel HBV reporter system, HBV-HiBiT-PS2, to screen new drugs for CHB. HBV-HiBiT-PS2 was constructed by introducing a HiBiT-tag at the 5’-end of PreS2 and introdu…
PLoS One Infectious Diseases
13.07.2024
by Bantie Getnet Yirsaw, Muluken Chanie Agimas, Gebrie Getu Alemu, Tigabu Kidie Tesfie, Nebiyu Mekonnen Derseh, Habtamu Wagnew Abuhay, Meron Asmamaw Alemayehu, Getaneh Awoke Yismaw . Introduction Hepatitis B virus (HBV) is one of the major public health problems globally and needs an urgent response. It is one of the most responsible causes of mortality among the five hepatitis viruses, and it affects almost every class of individuals. Different studies were conducted on the prevalence of HBV among pregnan…
PLoS One Infectious Diseases
11.07.2024
by Gemeda Wakgari Kitil, Abiy Tasew Dubale, Adamu Ambachew Shibabaw, Alex Ayenew Chereka . Background Hepatitis B virus infection remains a significant public health concern globally, particularly among healthcare workers, including health science students who are at high risk due to their exposure to infected patients and contaminated medical equipment. In Ethiopia, where the burden of HBV infection is substantial, preventive practices among health science students are critical for minimizing transmission…
Journal of Infectious Diseases
8.07.2024
Abstract . Background . The change of serum hepatitis B surface antigen (HBsAg) during treatment are associated with HBsAg loss. However, little is known about the trajectory patterns of HBsAg in early treatment and their relationship with subsequent HBsAg loss. This study aimed to identify trajectories of HBsAg in children with HBeAg-positive chronic hepatitis B (CHB) and investigate the association between trajectory patterns and HBsAg loss.Methods . A retrospective study was conducted on 166 treatment-na…
BMC Infectious Diseases
4.07.2024
. Abstract. . Background. Healthcare Workers (HCWs) are susceptible to hepatitis B virus (HBV) infection and are advised to receive vaccination. However, vaccination rates remain low in developing countries. There is little data concerning Hepatitis B (HepB) vaccination and information regarding HBV knowledge among HCWs in Cambodia. This study aimed to evaluate the knowledge of HBV infection, HepB vaccine, and vaccination…
BMC Infectious Diseases
2.07.2024
. Abstract. . Background. Healthcare Workers (HCWs) are susceptible to hepatitis B virus (HBV) infection and are advised to receive vaccination. However, vaccination rates remain low in developing countries. There is little data concerning Hepatitis B (HepB) vaccination and information regarding HBV knowledge among HCWs in Cambodia. This study aimed to evaluate the knowledge of HBV infection, HepB vaccine, and vaccination…
Journal of Medical Virology
30.06.2024
Journal of Medical Virology, Volume 96, Issue 7, July 2024.
BMC Infectious Diseases
27.06.2024
… Abstract. . Background. This study aimed to evaluate the diagnostic abilities of the non-invasive serum biomarkers to predict liver fibrosis staging and evaluate the progress of hepatitis B. . . . Methods. We enrolled 433 patients with chronic HBV infection had complete medical data available for the study, who underwent percutaneous liver biopsy.…
PLoS One Infectious Diseases
26.06.2024
by Emmanuel Salia, Yvonne Ayerki Nartey, Francis Tanam Djankpa, Faustina Pappoe, Samuel Victor Nuvor, Dorcas Obiri-Yeboah . Hepatitis B virus (HBV) constitutes a significant global health challenge, with more than 2 billion people infected globally and almost 291 million chronic cases. In Africa, coinfection of HBV with Human Immunodeficiency Virus (HIV) is high, yet the condition remains overlooked in many countries. While antiretroviral therapy (ART) has improved HIV survival, viral hepatitis continues t…
Journal of Infectious Diseases
26.06.2024
BMC Infectious Diseases
24.06.2024
. Abstract. . Background. Currently, several studies have observed that chronic hepatitis B virus infection is associated with the pathogenesis of kidney disease. However, the extent of the correlation between hepatitis B virus infection and the chronic kidney disease risk remains controversial. . . . Methods. In the present study, we search…
BMC Infectious Diseases
23.06.2024
. Abstract. . Background. Toll-Like receptors (TLRs) play an important role in the immune response during hepatitis B virus (HBV) infection. In this study, we evaluated the association between two SNP variants (TLR3 rs3775290 and TLR4 rs4986790) and susceptibility to chronic HBV infection in Mauritania. . . . Subjects and methods. : A total …
Journal of Medical Virology
21.06.2024
Journal of Medical Virology, Volume 96, Issue 6, June 2024.
Clinical Infectious Diseases
20.06.2024
Abstract . This prospective study enrolled healthcare workers (HCW) who were nonresponders following at least 5 doses of aluminum-adjuvanted hepatitis B vaccine received the 2-dose Heplisav-B (HepB-CpG) series. After two doses of HepB-CpG, 43/47 (91%) participants, and with 1 dose 41/49 (84%) responded. HepB-CpGcould be the preferred vaccine in HCW nonresponders.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Morbidity and Mortality Weekly Report (MMWR)
25.07.2024
This report describes vaccination efforts to eliminate mother-to-child hepatitis B.
Medscape Infectious Diseases
15.05.2024
The U.S. drug regulator has declined to approve expanded use of Dynavax Technologies' hepatitis B vaccine in a section of patients, citing insufficient data over destruction. . Reuters Health Information
Eurosurveillance latest updates
28.07.2023
. Background. The burden of chronic hepatitis B virus (HBV) varies across the European Union (EU) and European Economic Area (EEA). . . Aim. We aimed to update the 2017 HBV prevalence estimates in EU/EEA countries and the United Kingdom for 2018 to 2021. . . Methods. We undertook a systematic review, adding to HBV prevalence estimates from an existing (2005–2017) database. Databases were searched for original English-language research articles including HBV surface antigen prevalence estimates among t…
Eurosurveillance latest updates
28.07.2023
. Background. Georgia has adopted the World Health Organization European Region’s and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus (HBV) surface antigen (HBsAg) and 25.9% for antibodies against HBV core antigen (anti-HBc). HBV infection prevalence among children had previously not been assessed. . . Aim. We aimed to assess HBV infection prevalence among children and update estimates for adults in Georgia. . . Metho…
Morbidity and Mortality Weekly Report (MMWR)
21.07.2023
This report describes progress towards hepatitis B control and elimination in the World Health Organization African region.
Medscape Infectious Diseases
28.06.2023
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis. . Medscape Medical News
Medscape Infectious Diseases
11.04.2023
When researchers compared patients who met treatment criteria, treatment initiation was similar across races and socioeconomic status. But that finding raises other questions. . Medscape Medical News
Medscape Infectious Diseases
10.03.2023
The previous risk-based testing approach was not successful at detecting most people living with chronic hepatitis B infection, the agency said. . Medscape Medical News
Eurosurveillance latest updates
9.02.2023
. Background. The World Health Organization European Action Plan 2020 targets for the elimination of viral hepatitis are that > 75% of eligible individuals with chronic hepatitis B (HBV) or hepatitis C (HCV) are treated, of whom > 90% achieve viral suppression. Aim. To report the results from a pilot sentinel surveillance to monitor chronic HBV and HCV treatment uptake and outcomes in 2019. Methods. We undertook retrospective enhanced data collection on patients with a confirme…
Statens Serum Institut
22.12.2022
Antallet af tilfælde med akut hepatitis B er fortsat lavt i Danmark. Kronisk hepatitis B er faldende.
Medscape Infectious Diseases
12.08.2022
Progress has occurred in reducing maternal-to-child transmission of hepatitis B, a leading cause of liver cancer, but is lagging, particularly in Africa. .
Morbidity and Mortality Weekly Report (MMWR)
28.07.2022
This report describes global progress towards the elimination of mother-to-child hepatitis B virus.
Morbidity and Mortality Weekly Report (MMWR)
31.03.2022
This report describes updated hepatitis B vaccination recommendations from the Advisory Committee on Immunization Practices.
Medscape Infectious Diseases
1.03.2022
The three-antigen hepatitis B vaccine received approval from the FDA in November 2021. .
Medscape Infectious Diseases
17.12.2021
With hepatitis B vaccination rates low and infection rates rising, experts hope the new recommendations will raise clinician awareness and simplify screening.
Morbidity and Mortality Weekly Report (MMWR)
29.07.2021
This report describes progress toward hepatitis B control in the World Health Organization European Region.
Morbidity and Mortality Weekly Report (MMWR)
8.07.2021
This report describes donor-derived hepatitis B virus infections after liver transplantation.
Morbidity and Mortality Weekly Report (MMWR)
3.09.2020
This report describes the prevalence of past or present infection with hepatitis B virus among adults by race and Hispanic origin during 1999-2018.
Morbidity and Mortality Weekly Report (MMWR)
27.08.2020
This report describes a funding program in Uzbekistan designed to identify and treat cases of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection at a lowered cost with the goal of meeting the World Health Organization's targets to eliminate HBC and HCV infection.
Morbidity and Mortality Weekly Report (MMWR)
30.07.2020
This report describes progress of countries in the World Health Organization's South-East Asia region toward reaching 90% hepatitis B vaccination coverage.